Lv5
810 积分 2024-01-12 加入
Telitacicept as an alternative to non-steroidal immunosuppressive therapies in the treatment of myasthenia gravis: a study on clinical efficacy and steroid-sparing effect
4天前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
5天前
已完结
Belimumab treatment of adult idiopathic inflammatory myopathy
3个月前
已关闭
Belimumab treatment of adult idiopathic inflammatory myopathy
3个月前
已完结
Telitacicept add-on therapy in refractory idiopathic inflammatory myopathy: insights from a pilot study
4个月前
已完结
Telitacicept add-on therapy in refractory idiopathic inflammatory myopathy: insights from a pilot study
4个月前
已关闭
Complement system activation: bridging physiology, pathophysiology, and therapy
5个月前
已完结
Precision medicine for autoimmune disease
5个月前
已完结
Sequential immunotherapy: towards cures for autoimmunity
5个月前
已完结
The BAFF / APRIL system as therapeutic target in multiple sclerosis
9个月前
已完结
皖公网安备34019202002308
